search button

MicroRNA‑145‑5p attenuates high glucose‑induced apoptosis by targeting the Notch signaling pathway in podocytes

  • Authors:
    • Bing Wei
    • Yi‑Song Liu
    • Hai‑Xia Guan

  • View Affiliations

  • Published online on: January 7, 2020     https://doi.org/10.3892/etm.2020.8427
  • Pages: 1915-1924
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

MicroRNAs (miRNAs/miRs) are considered to serve essential roles in podocyte apoptosis, and to be critical in the development of diabetic nephropathy (DN). Activation of the Notch signaling pathway has been demonstrated to serve an important role in DN development; however, its regulatory mechanisms are not fully understood. The present study used a high glucose (HG)‑induced in vitro apoptosis model using mouse podocytes. Expression levels of miR‑145‑5p and its target, Notch1, and other key factors involved in the apoptosis signaling pathway were detected and measured by reverse transcription‑quantitative PCR and western blotting. A luciferase reporter assay was performed to elucidate the miRNA‑target interactions. The functions of miR‑145‑5p in apoptosis were detected using flow cytometry and TUNEL staining. The present study demonstrated that in HG conditions, miR‑145‑5p overexpression inhibited Notch1, Notch intracellular domain, Hes1 and Hey1 expression at the mRNA and protein levels. Notch1 was identified as a direct target of miR‑145‑5p. Furthermore, cleaved caspase‑3, Bcl‑2 and Bax levels were reduced significantly by miR‑145‑5p overexpression. These results indicate that miR‑145‑5p overexpression inhibited the Notch signaling pathway and podocyte lesions induced by HG. In conclusion, the results of the present study suggested that miR‑145‑5p may be a regulator of DN. Additionally, miR‑145‑5p inhibited HG‑induced apoptosis by directly targeting Notch1 and dysregulating apoptotic factors, including cleaved caspase‑3, Bcl‑2 and Bax. The results of the present study provided evidence that miR‑145‑5p may offer a novel approach for the treatment of DN.
View Figures
View References

Related Articles

Journal Cover

March-2020
Volume 19 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.7
  • Ranked Medicine Research and Experimental
    (total number of cites)
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Wei B, Liu YS and Guan HX: MicroRNA‑145‑5p attenuates high glucose‑induced apoptosis by targeting the Notch signaling pathway in podocytes. Exp Ther Med 19: 1915-1924, 2020
APA
Wei, B., Liu, Y., & Guan, H. (2020). MicroRNA‑145‑5p attenuates high glucose‑induced apoptosis by targeting the Notch signaling pathway in podocytes. Experimental and Therapeutic Medicine, 19, 1915-1924. https://doi.org/10.3892/etm.2020.8427
MLA
Wei, B., Liu, Y., Guan, H."MicroRNA‑145‑5p attenuates high glucose‑induced apoptosis by targeting the Notch signaling pathway in podocytes". Experimental and Therapeutic Medicine 19.3 (2020): 1915-1924.
Chicago
Wei, B., Liu, Y., Guan, H."MicroRNA‑145‑5p attenuates high glucose‑induced apoptosis by targeting the Notch signaling pathway in podocytes". Experimental and Therapeutic Medicine 19, no. 3 (2020): 1915-1924. https://doi.org/10.3892/etm.2020.8427